Houlihan Lokey (HLI) Scheduled to Post Quarterly Earnings on Wednesday

Houlihan Lokey (NYSE:HLI) is set to post its quarterly earnings results after the market closes on Wednesday, October 30th. Analysts expect Houlihan Lokey to post earnings of $1.31 per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Houlihan Lokey (NYSE:HLI) last announced its quarterly earnings results on Tuesday, July 30th. The financial services provider reported $1.22 EPS for the quarter, hitting the consensus estimate of $1.22. The company had revenue of $514.00 million during the quarter, compared to analyst estimates of $508.70 million. Houlihan Lokey had a return on equity of 18.80% and a net margin of 15.30%. The firm’s revenue was up 23.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.89 earnings per share. On average, analysts expect Houlihan Lokey to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Houlihan Lokey Stock Down 1.6 %

Shares of HLI stock opened at $169.60 on Wednesday. The stock has a market cap of $11.63 billion, a price-to-earnings ratio of 41.27 and a beta of 0.66. The firm’s 50 day moving average price is $158.04 and its two-hundred day moving average price is $143.28. Houlihan Lokey has a fifty-two week low of $94.67 and a fifty-two week high of $175.21.

Houlihan Lokey Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Sunday, September 15th. Shareholders of record on Tuesday, September 3rd were given a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.34%. The ex-dividend date was Tuesday, September 3rd. Houlihan Lokey’s dividend payout ratio (DPR) is presently 55.47%.

Insider Buying and Selling at Houlihan Lokey

In other news, Director Gillian Beth Zucker sold 200 shares of Houlihan Lokey stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $152.49, for a total value of $30,498.00. Following the completion of the transaction, the director now owns 7,001 shares in the company, valued at approximately $1,067,582.49. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Houlihan Lokey news, Chairman Scott L. Beiser sold 8,317 shares of the firm’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $151.89, for a total value of $1,263,269.13. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Gillian Beth Zucker sold 200 shares of the company’s stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $152.49, for a total value of $30,498.00. Following the transaction, the director now directly owns 7,001 shares of the company’s stock, valued at $1,067,582.49. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 9,917 shares of company stock worth $1,513,129 over the last quarter. 25.97% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Keefe, Bruyette & Woods restated a “market perform” rating and issued a $154.00 price target (up previously from $139.00) on shares of Houlihan Lokey in a report on Wednesday, July 31st. JPMorgan Chase & Co. dropped their price target on shares of Houlihan Lokey from $132.00 to $129.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 31st. Wells Fargo & Company began coverage on shares of Houlihan Lokey in a report on Thursday, September 12th. They issued an “underweight” rating and a $149.00 price objective on the stock. UBS Group raised their target price on Houlihan Lokey from $170.00 to $190.00 and gave the company a “buy” rating in a research note on Tuesday, October 8th. Finally, Morgan Stanley boosted their price target on Houlihan Lokey from $146.00 to $163.00 and gave the stock an “equal weight” rating in a research note on Monday, September 23rd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $157.00.

About Houlihan Lokey

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.